European Journal of Clinical Pharmacology

Title Publication Date Language Citations
Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database2012/03/25English127
Beyond lipid-lowering: effects of statins on endothelial nitric oxide2003/02/18English127
Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union1997/09/25126
The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers2008/11/04English126
Impact of inappropriate drug use among hospitalized older adults2005/05/24English125
The consumption of drugs by 75-year-old individuals living in their own homes2000/09/20123
Urinary 6?-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals2003/12/01123
Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins)2001/07/13English122
Methods for estimating the occurrence of polypharmacy by means of a prescription database1997/10/02122
In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors1996/05/14121
Heavy metals in traditional Indian remedies2001/12/08English120
Pharmacokinetics and dose requirements of factor VIII over the age range 3–74 years2009/06/26English120
Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications2014/05/03English120
Incidence of drug-induced liver injury in medical inpatients2005/02/23English119
Blood−brain barrier transporters and response to CNS-active drugs2009/09/02English118
Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects2014/08/28English116
Esomeprazole 40�mg provides more effective intragastric acid control than lansoprazole 30�mg, omeprazole 20�mg, pantoprazole 40�mg and rabeprazole 20�mg in patients with gastro-oesophageal reflux symptoms2004/09/02English116
Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews2012/07/29English116
Agranulocytosis associated with dipyrone (metamizol)2004/12/03English113
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping2007/02/02English112
Polymorphic CYP2D6 mediates O -demethylation of the opioid analgesic tramadol1997/12/15112
Vancomycin dosing in morbidly obese patients1998/11/11112
Therapeutic drug monitoring of oral targeted antineoplastic drugs2020/11/09English111
The effect of variable cigarette consumption on the interaction with clozapine and olanzapine2006/11/07English111
Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients2007/09/29English110
The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression2009/04/17English110
Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions2000/03/24109
Patterns and correlates of benzodiazepine use in the French general population2004/08/28English109
A signal for an abuse liability for pregabalin—results from the Swedish spontaneous adverse drug reaction reporting system2010/06/19English109
Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits2011/02/12English109